Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Molecular Pathology, |
RCV003447758 | SCV004175469 | likely pathogenic | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | 2021-12-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003669422 | SCV004386755 | uncertain significance | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in individual(s) with May-Hegglin anomaly (Invitae). This variant is not present in population databases (gnomAD no frequency). This variant, c.4357_4359del, results in the deletion of 1 amino acid(s) of the MYH9 protein (p.Glu1453del), but otherwise preserves the integrity of the reading frame. |